# Buffered vs Plain Lidocaine for Local Nasal Anesthesia

> **NCT04583137** · EARLY_PHASE1 · UNKNOWN · sponsor: **Kfir Siag** · enrollment: 80 (estimated)

## Conditions studied

- Anesthesia, Local

## Interventions

- **DRUG:** Lidocain

## Key facts

- **NCT ID:** NCT04583137
- **Lead sponsor:** Kfir Siag
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04583137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04583137, "Buffered vs Plain Lidocaine for Local Nasal Anesthesia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04583137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*